Strong first-day trading for iX Biopharma
Shares close trading up 21.7 per cent at S$0.56 after intra-day high of S$0.64
Add BT as a preferred sourceSingapore
SPECIALTY pharmaceutical company iX Biopharma made a strong trading debut on the Singapore Exchange Catalist board on Wednesday.
Shares of iX Biopharma, the second healthcare company in less than two months to breathe life into an otherwise moribund initial public offering (IPO) market, kicked off trading at S$0.495, 3.5 Singapore cents or 7.6 per cent above its IPO price of S$0.46.
TRENDING NOW
Two-thirds of Sentosa Cove resales in the red, with average loss topping S$1 million since 2023
How BYD disrupted Singapore’s car market – and why the strategy is turning on itself
After a strong Q2, what’s next for Singapore banks? Analysts see DBS, OCBC ahead on wealth
Laos-China Railway picks up steam, but S-E Asian country struggles to capture gains
